Gyrase inhibitors and topoisomerase IV pyrimidine

2012 
A compound of formula ** ** Formula wherein R is hydrogen or fluorine; X is hydrogen, -PO (OH) 2, -PO (OH) O-M +, -PO (O-) 2 * 2M + or -PO (O-) 2 D2 + *; M + is a pharmaceutically acceptable monovalent cation; and D2 + is a pharmaceutically acceptable divalent cation; or a pharmaceutically acceptable salt thereof.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []